Search

Your search keyword '"Ajana, F"' showing total 522 results

Search Constraints

Start Over You searched for: Author "Ajana, F" Remove constraint Author: "Ajana, F"
522 results on '"Ajana, F"'

Search Results

1. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France

14. Endoscopic ampullectomy: case report

21. Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial

23. Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

26. Spontaneous biliary digestive fistulas

28. Endoscopic ampullectomy

34. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

35. No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy

36. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

38. Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study

39. Levels and determinants of breast and cervical cancer screening uptake in HIV‐infected women compared with the general population in France

43. Efficacy and Safety of Switching to Dolutegravir/Lamivudine (DTG/3TC) Versus Continuing a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With HIV-1: Results Through Week 144 From the Phase 3, Non-inferiority TANGO Randomized Trial

44. Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial

46. No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study

47. Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission

48. Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

49. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

50. Vaccination in adults with auto-immune disease and/or drug related immune deficiency: Results of the GEVACCIM Delphi survey

Catalog

Books, media, physical & digital resources